Insider trading

Period: 120 months Stock: PHR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

437 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

437 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

437 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

437 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
437 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
437 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

437 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Jan 2024
Gunzburg Janet Principal Accounting Officer
Sold on a plan
$4.94K 205 at 24.11
0.5%
Planned (10b5-1)
19 Dec 2023
Gunzburg Janet Principal Accounting Officer
Sold at will
$2.80K 118 at 23.72
0.3%
Not planned
19 Dec 2023
Linetsky David SVP, Life Sciences · indirect
Sold at will
$593.08 25 at 23.72
0.3%
Not planned
18 Dec 2023
Linetsky David SVP, Life Sciences · indirect
Sold at will 2×
$7.73K 334 at 23.15
4.2%
Not planned
1 Nov 2023
Gunzburg Janet Principal Accounting Officer
Sold at will
$3.99K 298 at 13.38
0.7%
Not planned
16 Oct 2023
Indig Chaim Chief Executive Officer
Sold at will
$54.73K 3,295 at 16.61
0.3%
Not planned
16 Oct 2023
Linetsky David SVP, Life Sciences
Sold at will
$34.51K 2,078 at 16.61
1.0%
Not planned
16 Oct 2023
Roberts Evan Chief Operating Officer
Sold at will
$32.74K 1,971 at 16.61
0.3%
Not planned
16 Oct 2023
Hoffman Allison C General Counsel & Secretary
Sold at will
$21.54K 1,297 at 16.61
1.1%
Not planned
16 Oct 2023
Davidoff Michael J. SVP, Payer Business
Sold at will
$19.90K 1,198 at 16.61
1.3%
Not planned
16 Oct 2023
Gandhi Balaji Chief Financial Officer
Sold at will
$14.30K 861 at 16.61
1.0%
Not planned
16 Oct 2023
VanDuyn Amy Beth SVP, Human Resources
Sold at will
$11.04K 665 at 16.61
0.6%
Not planned
18 Sep 2023
Linetsky David SVP, Life Sciences · indirect
Sold at will 3×
$2.56K 130 at 19.67
1.6%
Not planned
18 Sep 2023
Gunzburg Janet Principal Accounting Officer
Sold at will
$2.47K 125 at 19.79
0.3%
Not planned
14 Sep 2023
Davidoff Michael J. SVP, Payer Business
Sold on a plan
$59.54K 2,953 at 20.16
3.1%
Planned (10b5-1)
14 Sep 2023
Hoffman Allison C General Counsel & Secretary
Sold on a plan
$44.57K 2,210 at 20.17
1.9%
Planned (10b5-1)
14 Sep 2023
VanDuyn Amy Beth SVP, Human Resources
Sold on a plan
$40.32K 2,000 at 20.16
1.7%
Planned (10b5-1)
13 Sep 2023
Indig Chaim Chief Executive Officer
Sold at will 2×
$133.32K 6,555 at 20.34
0.5%
Not planned
13 Sep 2023
Gandhi Balaji Chief Financial Officer
Sold at will 2×
$80.48K 3,957 at 20.34
4.4%
Not planned
13 Sep 2023
Roberts Evan Chief Operating Officer
Sold at will 2×
$79.46K 3,907 at 20.34
0.5%
Not planned
13 Sep 2023
Davidoff Michael J. SVP, Payer Business
Sold on a plan 2×
$73.34K 3,606 at 20.34
3.6%
Planned (10b5-1)
13 Sep 2023
Hoffman Allison C General Counsel & Secretary
Sold on a plan 2×
$66.22K 3,256 at 20.34
2.7%
Planned (10b5-1)
13 Sep 2023
Linetsky David SVP, Life Sciences
Sold at will 2×
$41.88K 2,059 at 20.34
0.9%
Not planned
13 Sep 2023
VanDuyn Amy Beth SVP, Human Resources
Sold on a plan 2×
$37.14K 1,826 at 20.34
1.5%
Planned (10b5-1)
13 Sep 2023
Gunzburg Janet Principal Accounting Officer
Sold at will 2×
$19.00K 934 at 20.34
2.2%
Not planned
13 Sep 2023
Linetsky David SVP, Life Sciences · indirect
Sold at will 2×
$2.42K 119 at 20.34
1.5%
Not planned
21 Jul 2023
Davidoff Michael J. SVP, Payer Business
Sold on a plan
$34.13K 1,075 at 31.75
1.1%
Planned (10b5-1)
10 May 2023
Munson Gillian Director
Sold on a plan
$106.86K 3,555 at 30.06
15.5%
Planned (10b5-1)
21 Apr 2023
Davidoff Michael J. SVP, Payer Business
Sold on a plan
$35.61K 1,075 at 33.13
1.1%
Planned (10b5-1)
18 Apr 2023
Roberts Evan Chief Operating Officer
Sold on a plan
$239.17K 7,452 at 32.09
1.0%
Planned (10b5-1)
17 Apr 2023
Roberts Evan Chief Operating Officer
Sold on a plan
$83.23K 2,600 at 32.01
0.4%
Planned (10b5-1)
17 Apr 2023
Gandhi Balaji Chief Financial Officer
Sold on a plan
$67.25K 2,113 at 31.83
2.4%
Planned (10b5-1)
17 Apr 2023
VanDuyn Amy Beth SVP, Human Resources
Sold at will
$18.15K 570 at 31.84
0.5%
Not planned
14 Apr 2023
Hoffman Allison C General Counsel & Secretary
Sold on a plan
$103.02K 3,306 at 31.16
2.5%
Planned (10b5-1)
12 Apr 2023
Roberts Evan Chief Operating Officer
Sold on a plan
$6.40K 200 at 32.01
0.0%
Planned (10b5-1)
11 Apr 2023
Davidoff Michael J. SVP, Payer Business
Sold on a plan
$107.12K 3,466 at 30.91
3.4%
Planned (10b5-1)
3 Apr 2023
Sold on a plan 2×
$215.37K 7,000 at 30.77
30.3%
Planned (10b5-1)
3 Apr 2023
VanDuyn Amy Beth SVP, Human Resources
Sold on a plan 2×
$91.70K 2,978 at 30.79
3.0%
Planned (10b5-1)
2 Feb 2023
Linetsky David SVP, Life Sciences
Sold, plan not stated
$449.99K 11,378 at 39.55
5.2%
2 Feb 2023
Davidoff Michael J. SVP, Payer Business
Sold, plan not stated 2×
$294.56K 7,513 at 39.21
7.1%
2 Feb 2023
Rasmussen Randy Chief Financial Officer
Sold, plan not stated
$190.60K 4,765 at 40.00
3.2%
2 Feb 2023
VanDuyn Amy Beth SVP, Human Resources
Sold, plan not stated
$12.00K 300 at 40.00
0.3%
31 Jan 2023
Davidoff Michael J. SVP, Payer Business
Sold, plan not stated
$124.08K 3,265 at 38.00
3.0%
30 Jan 2023
Davidoff Michael J. SVP, Payer Business
Sold, plan not stated 2×
$1.03M 28,555 at 36.10
20.8%
18 Jan 2023
Hoffman Allison C General Counsel & Secretary
Sold, plan not stated
$23.41K 649 at 36.07
0.5%
3 Jan 2023
Roberts Evan Chief Operating Officer
Sold, plan not stated 3×
$313.55K 10,000 at 31.36
1.4%
20 Dec 2022
VanDuyn Amy Beth SVP, Human Resources
Sold, plan not stated
$12.75K 378 at 33.73
0.4%
15 Dec 2022
Linetsky David SVP, Life Sciences · indirect
Sold at will
$748.22 22 at 34.01
0.2%
Not planned
14 Dec 2022
Hoffman Allison C General Counsel & Secretary
Sold, plan not stated
$28.84K 801 at 36.00
0.8%
13 Dec 2022
Linetsky David SVP, Life Sciences
Sold, plan not stated
$393.75K 11,377 at 34.61
5.8%
Showing 251–300 of 437. ← Newer Page 6 of 9 Older →